Accès gratuit
Numéro
Med Sci (Paris)
Volume 30, Numéro 4, Avril 2014
Page(s) 391 - 397
Section Microenvironnements tumoraux : conflictuels et complémentaires
DOI https://doi.org/10.1051/medsci/20143004012
Publié en ligne 5 mai 2014
  1. Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Biol 2010 ; 188 : 11–19. [CrossRef] [PubMed]
  2. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006 ; 6 : 392–401. [CrossRef] [PubMed]
  3. Qian LW, Mizumoto K, Maehara N, et al. Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts: fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production. Cancer Lett 2003 ; 190 : 105–112. [CrossRef] [PubMed]
  4. Wilson TR, Fridlyand J, Yan Y, et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012 ; 487 : 505–509. [CrossRef] [PubMed]
  5. Ottaviano AJ, Sun L, Ananthanarayanan V, Munshi HG. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1. Cancer Res 2006 ; 66 : 7032–7040. [CrossRef] [PubMed]
  6. Mueller MM, Fusenig NE. Friends or foes - Bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004 ; 4 : 839–849. [CrossRef] [PubMed]
  7. Trimboli AJ, Cantemir-Stone CZ, Li F, et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 2009 ; 461 : 1084–1091. [CrossRef] [PubMed]
  8. Erez N, Truitt M, Olson P, et al. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010 ; 17 : 135–147. [CrossRef] [PubMed]
  9. Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005 ; 121 : 335–348. [CrossRef] [PubMed]
  10. Butcher DT, Alliston T, Weaver VM. A tense situation: forcing tumour progression. Nat Rev Cancer 2009 ; 9 : 108–122. [CrossRef] [PubMed]
  11. Malanchi I, Santamaria-Martínez A, Susanto E, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 2012 ; 481 : 85–89. [CrossRef]
  12. Goetz JG, Del Pozo MA. La cavéoline-1 force le remodelage de la matrice extracellulaire. Med Sci (Paris) 2011 ; 27 : 940–944. [CrossRef] [EDP Sciences] [PubMed]
  13. Gaggioli C, Hooper S, Hidalgo-Carcedo C, et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 2007 ; 9 : 1392–1400. [CrossRef] [PubMed]
  14. Grinnell F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 2003 ; 13 : 264–269. [CrossRef] [PubMed]
  15. Meshel AS, Wei Q, Adelstein RS, Sheetz MP. Basic mechanism of three-dimensional collagen fibre transport by fibroblasts. Nat Cell Biol 2005 ; 7 : 157–164. [CrossRef] [PubMed]
  16. Davis J, Burr AR, Davis GF, et al. A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. Dev Cell 2012 ; 23 : 705–715. [CrossRef] [PubMed]
  17. Dees C, Tomcik M, Palumbo-Zerr K, et al. JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor beta in systemic sclerosis. Arthritis Rheum 2012 ; 64 : 3006–3015. [CrossRef] [PubMed]
  18. Barker HE, Cox TR, Erler JT. The rationale for targeting the LOX family in cancer. Nat Rev Cancer 2012 ; 12 : 540–552. [CrossRef] [PubMed]
  19. Levental, KR, Yu H, Kass L, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009 ; 139 : 891–906. [CrossRef] [PubMed]
  20. Wolf K, Wu YI, Liu Y, et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 2007 ; 9 : 893–904. [CrossRef] [PubMed]
  21. D’Angelo M, Billings PC, Pacifici M, et al. Authentic matrix vesicles contain active metalloproteases (MMP): a role for matrix vesicle-associated MMP-13 in activation of transforming growth factor-beta. J Biol Chem 2001 ; 276 : 11347–11353. [CrossRef] [PubMed]
  22. Bergers G, Brekken R, McMahon G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000 ; 2 : 737–744. [CrossRef] [PubMed]
  23. Lochter A, Galosy S, Muschler J, et al. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 1997 ; 139 : 1861–1872. [CrossRef] [PubMed]
  24. Giannoni E, Bianchini F, Masieri L, et al. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res 2010 ; 70 : 6945–6956. [CrossRef] [PubMed]
  25. Boire A, Covic L, Agarwal A, et al. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 2005 ; 120 : 303–313. [CrossRef] [PubMed]
  26. Overall CM, Kleifeld O. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 2006 ; 6 : 227–239. [CrossRef] [PubMed]
  27. Provot S. Contrôle de la croissance et de la dissémination tumorales par le microenvironnement : certitudes et hypothèses émergentes. Med Sci (Paris) 2014 ; 30 : 366–371. [CrossRef] [EDP Sciences] [PubMed]
  28. Hubert S, Abastado JP. Les étapes précoces du processus métastatique. Med Sci (Paris) 2014 ; 30 : 378–384. [CrossRef] [EDP Sciences] [PubMed]
  29. Buache E, Rio MC. Le stroma tumoral, un terreau fertile pour la cellule cancéreuse. Med Sci (Paris) 2014 ; 30 : 385–390. [CrossRef] [EDP Sciences] [PubMed]
  30. Le Guellec S, Duprez-Paumier R, Lacroix-Triki M. Microenvironnement tumoral : la vision du pathologiste. Med Sci (Paris) 2014 ; 30 : 372–377. [CrossRef] [EDP Sciences] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.